Highlights
AMEX: PLX       Protalix Biotherapeutics
Last Price Today's Change   Day's Range   Trading Volume
0.31   +0.006 (1.97%)  0.291 - 0.31  310,200

Overview

 
Avg Volume (4 weeks):1,288,340
4 Weeks Range:0.185 - 0.36
4 Weeks Price Volatility (%):
71.43%
52 Weeks Range:0.17 - 0.60
52 Weeks Price Volatility (%):
32.56%
Average Price Target: 4.25
Price Target Upside/Downside: +3.94

Headlines



No recent Headlines for this stock.


Business Background

Protalix BioTherapeutics Inc is a part of the healthcare domain. It is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa, for the treatment of Gaucher disease. Its products also treat diseases like Fabry disease and cystic fibrosis. Its pipeline products include Alidornase Alfa, Pegunigalsidase Alfa, and Oprx-106.

  Be the first to like this.
 
ysabag with the new ceo it will raise above the target
29/07/2014 2:51 PM
Tygobar Yes, medical startups usually should very very good in everything like that really and totally , yet you do have very low price of the stock here, how can you really even describe this ? Could you damn let me know this please. I am all ears for example.
01/09/2019 1:12 PM
Lalis I do hope that medical things will be really our future and not just cause it cause something for example good for now, but in the real perspective for many many generations ahead totally. But for now of course I plan to invest a lot in such things.
07/09/2019 1:56 PM


 

4706  3347  638  230 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GDX 26.97-0.65 
 CHK 0.76+0.041 
 EEM 43.07+0.25 
 BAC 33.67+0.58 
 GE 11.10+0.31 
 SPY 314.87+2.85 
 XOP 21.23+0.74 
 VIAB 24.22+0.75 
 ONTX 0.35+0.058 
Partners & Brokers